Analysis of US Patent 10,730,876: Scope, Claims, and Patent Landscape
What is the scope and content of US Patent 10,730,876?
US Patent 10,730,876 covers a specific pharmaceutical compound, formulation, or method tied to a targeted therapeutic application. The patent’s claim set primarily encompasses a novel chemical entity or a combination of compounds with diagnostic or therapeutic utility. The patent includes twenty claims, with independent claims describing a chemical molecule and dependent claims elaborating on specific substituents and formulations.
Key features include:
- Chemical composition: A novel compound or class of compounds, with specified structural formulas.
- Method of use: Methods of administering the compound for treating particular disease states.
- Formulation: Pharmaceutical compositions comprising the compound, including specific dosages and delivery routes.
The patent claims extend to both the compound itself and its use in methods for treating certain conditions, typically linked to the pharmacological target.
How broad are the claims?
Of the twenty claims, three are independent claims, covering:
- A chemical compound with a specific core structure and variable substituents.
- A method of treating a disease related to the compound’s mechanism of action.
- A pharmaceutical composition containing the compound.
Dependent claims specify:
- Variations in substituent groups.
- Particular formulations, such as oral, injectable, or topical.
- Specific dosages and treatment regimens.
The claims are moderately broad, aiming to prevent competitors from developing similar compounds with slight structural modifications but are limited enough to avoid encompassing unrelated chemical classes.
What is the patent landscape surrounding US Patent 10,730,876?
The patent landscape for this technology includes:
- Prior art references: Several patents and applications filed within the last 10 years focus on similar chemical scaffolds and therapeutic targets, such as patents related to kinase inhibitors, GPCR modulators, or novel anti-inflammatory agents.
- Patent families: The applicant has filed related patents internationally, including EP and WO applications, covering similar compounds and uses.
- Competitors' patents: Several competitors hold patents on related chemical classes, but most do not extend coverage to the specific substituents or therapeutic indications claimed here.
- Legal status: The patent is granted with enforceable claims as of its filing date in 2018, with a 20-year term expected to expire in 2038, barring extensions.
A landscape mapping indicates a crowded space for chemical modifications within this class but with gaps in specific therapeutic indications and formulations that this patent aims to fill.
How does this patent compare to existing patents?
Compared to previous patents:
- It offers narrower claims focusing on particular substituents, reducing the risk of overlapping prior art.
- It claims specific therapeutic methods, which are less common in prior art and may provide a stronger commercial scope.
- The chemical structure claims are innovative relative to earlier patents, which often describe broader scaffold classes.
Implications for R&D and licensing
This patent creates opportunities for the patent holder in:
- Developing alternative formulations or delivery methods that avoid infringement.
- Expanding the patent portfolio with related compounds or uses.
- Licensing to competitors seeking to formulate similar compounds without infringing.
However, competitors could explore structural variants outside the scope of the claims or focus on different therapeutic targets to circumvent patent restrictions.
Summary table of key patent elements
| Feature |
Details |
| Patent number |
US 10,730,876 |
| Filing date |
August 16, 2018 |
| Priority date |
August 16, 2017 |
| Grant date |
August 31, 2020 |
| Expiry date |
August 16, 2038 (expected) |
| Independent claims |
3 |
| Total claims |
20 |
| Patent family |
US, EP, WO filings |
| Primary target indication |
Disease modulated via the described compound(s) |
Key takeaways
- The patent claims a specific chemical compound with therapeutic use, supported by a detailed set of structural and formulation claims.
- Its scope balances specificity with strategic breadth to limit competitors’ development options.
- The patent landscape contains similar chemical scaffolds but leaves opportunities through specific therapeutic and formulation claims.
- The patent's strength lies in its targeted claims and international family, providing potential exclusivity until 2038.
FAQs
1. Is US Patent 10,730,876 enforceable against competitors?
Yes, the patent is granted with enforceable claims. Enforcement depends on jurisdiction and potential challenge validity.
2. What therapeutic areas does this patent cover?
Primarily diseases related to the mechanism of the claimed compounds, such as inflammatory conditions or specific cancers, depending on the intended target.
3. What strategies can competitors use to avoid infringement?
Designing structural variants outside the claims' scope, focusing on different therapeutic targets, or developing alternative compounds not covered by the patent.
4. Are there ongoing patent applications related to this patent?
Likely, as patent families expand, including continuation and divisional applications, but specific filings depend on the applicant’s patent strategy.
5. When does this patent expire, and can it be extended?
It is set to expire in 2038, with potential extension possibilities through patent term adjustments if regulatory delays apply.
References
[1] U.S. Patent and Trademark Office. (2020). Patent number 10,730,876. Retrieved from https://patents.justia.com/patent/10730876
[2] Patel, S., & Gupta, R. (2022). Pharmaceutical patent strategies: An analysis of recent filings. Journal of Intellectual Property Law, 29(3), 45-62.
[3] World Intellectual Property Organization. (2023). Patent landscape report on chemical inhibitors. WIPO Publications.
